2025年6月2日 周一
Home > Archive>Volume 33, Issue 1, 2025 >58-67
PDF HTML XML Export Cite reminder
The effect of cumulative non-high density lipoprotein cholesterol/high density lipoprotein cholesterol exposure on atherosclerotic cardiovascular disease
Author:
Affiliation:

1.Graduate School, North China University of Science and Technology, Tangshan, Hebei 063210, China;2.Kailuan General Hospital Affiliated to North China University of Science and Technology, Tangshan, Hebei 063000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [40]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Aim To investigate the effect of cumulative non-high density lipoprotein cholesterol/high density lipoprotein cholesterol (non-HDLC/HDLC) exposure on atherosclerotic cardiovascular disease(ASCVD). Methods A prospective cohort study was conducted. A total of 50 777 employees of Kailuan Group who participated in three physical examinations in 2006—7,8—2009 and 2010—2011 were selected as the study subjects. Groups were divided into Q1, Q2, Q3 and Q4 according to the cumulative non-HDLC/HDLC exposure quartiles. Kaplan-Meier curve was used to calculate the cumulative incidence of ASCVD in different cumulative non-HDLC/HDLC groups, and Log-rank test was used to compare the differences among groups. Cox proportional risk model was used to analyze the effect of cumulative non-HDLC/HDLC exposure on ASCVD. Results The average follow-up was (10.19±2.21) years, and 5 003 new cases of ASCVD occurred. The cumulative incidence of ASCVD in groups Q1 to Q4 was 6.49%, 8.71%, 10.86% and 14.85%, respectively(Log-rank P＜0.01). Multivariate Cox regression analysis showed that compared with group Q1, the HR(95%CI) of ASCVD in groups Q2, Q3 and Q4 were 1.13(1.03～1.24), 1.18(1.07～1.29), 1.22(1.12～1.34), respectively; the HR(95%CI) of myocardial infarction were 1.15(0.87～1.53), 1.44(1.10～1.88), 1.67 (1.29～2.17), respectively; the HR(95%CI) of revascularization were 1.21 (0.99～1.49), 1.31 (1.07～1.60) and 1.49(1.22～1.81), respectively; the HR(95%CI) of ischemic stroke were 1.17 (1.03～1.32), 1.17 (1.04～1.33) and 1.21 (1.06～1.37), respectively; but the above association was not found when heart failure and atrial fibrillation were used as the outcome events. The restricted cubic spline showed that cumulative non-HDLC/HDLC values were linearly associated with the risk of ASCVD. Conclusion Cumulative non-HDLC/HDLC exposure was positively associated with the risk of ASCVD.

    Reference
    [1] ROETERS VAN LENNEP J E, TOKGZOGˇLU L S, BADIMON L, et al.Women, lipids, and atherosclerotic cardiovascular disease:a call to action from the European atherosclerosis society.Eur Heart J, 3,4(39):4157-4173.
    [2] TSAO C W, ADAY A W, ALMARZOOQ Z I, et al.Heart disease and stroke statistics-2022 update:a report from the American heart association.Circulation, 2,5(8):e153-e639.
    [3] 《中国心血管健康与疾病报告2022》编写组.《中国心血管健康与疾病报告2022》概述.中国心血管病研究, 3,1(7):577-600.The Writing Committee of the Report on Cardiovascular Health and Diseases in China 2022.Overview of report on cardiovascular health and diseases in China 2022.Chin J Cardiovasc Res, 3,1(7):577-600.
    [4] 郭明秋, 殷晓捷, 刁殿琰, 等.脂质代谢水平与冠状动脉粥样硬化病变的关系.中国动脉硬化杂志, 1,9(2):149-155.GUO M Q, YIN X J, DIAO D Y, et al.Relationship between the levels of lipid metabolism and coronary atherosclerotic lesions.Chin J Arterioscler, 1,9(2):149-155.
    [5] National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ) final report.Circulation, 2,6(25):3143-3421.
    [6] LITING P, GUOPING L, ZHENYUE C.Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol.Predictive value for CHD severity and prognostic utility in CHD patients.Herz, 5,0(Suppl 1):1-7.
    [7] HONG L F, YAN X N, FAN Y, et al.Is the ratio of ApoB/ApoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.J Geriatr Cardiol, 5,2(4):402-409.
    [8] GUO J, WANG A, WANG Y, et al.Non-traditional lipid parameters as potential predictors of asymptomatic intracranial arterial stenosis.Front Neurol, 1,2:679415.
    [9] ZHAO W, GONG W, WU N, et al.Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese.Lipids Health Dis, 4,3:37.
    [10] ELIASSON B, CEDERHOLM J, EEG-OLOFSSON K, et al.Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes:a report from the swedish national diabetes register.Diabetes Care, 1,4(9):2095-2100.
    [11] PUNIC I, MIHAI A D, 瘙塁TEFAN S, et al.Comparative evaluation of LDL-C, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.J Diabetes Complications, 3,7(12):108634.
    [12] KAUNA M, CZLAPKA-MATYASIK M, KOMPF P, et al.Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.Ther Adv Endocrinol Metab, 2,3:20420188211066699.
    [13] PARK J H, LEE J, OVBIAGELE B.Nontraditional serum lipid variables and recurrent stroke risk.Stroke, 4,5(11):3269-3274.
    [14] KOUVARI M, PANAGIOTAKOS D B, CHRYSOHOOU C, et al.Sex-related differences of the effect of lipoproteins and apolipoproteins on 10-year cardiovascular disease risk; insights from the ATTICA study (2002-2012).Molecules, 0,5(7):1506.
    [15] LIU Z, LIN X, ZENG L, et al.Elevated non-HDL-C/HDL-C ratio increases the 1-year risk of recurrent stroke in older patients with non-disabling ischemic cerebrovascular events:results from the Xi'an stroke registry study of China.BMC Geriatr, 3,3(1):410.
    [16] 苏超, 张桂霞, 王瑞峰, 等.CKD-EPI方程估算中国慢性肾脏病患者肾小球滤过率的适用性评价.中华疾病控制杂志, 3,7(7):621-624.SU C, ZHANG G X, WANG R F, et al.Application of the CKD-EPI equation for estimation of glomerular filtration rate in Chinese patients with chronic kidney disease.Chin J Dis Control Prev, 3,7(7):621-624.
    [17] WU S, HUANG Z, YANG X, et al.Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city.Circ Cardiovasc Qual Outcomes, 2,5(4):487-493.
    [18] ZEMAITIS P, LIU K, JACOBS D R, et al.Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis.Clin J Am Soc Nephrol, 4,9(11):1922-1929.
    [19] 王艳秀, 刘爱华, 邢爱君, 等.累积血压暴露对新发心房颤动的预测价值.中国动脉硬化杂志, 9,7(4):354-358.WANG Y X, LIU A H, XING A J, et al.Predictive value of cumulative blood pressure exposure for new-onset atrial fibrillation.Chin J Arterioscler, 9,7(4):354-358.
    [20] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等.中国高血压防治指南(2018年修订版).中国心血管杂志, 9,4(1):24-56.Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al.2018 Chinese guidelines for the management of hypertension.Chin J Cardiovasc Med, 9,4(1):24-56.
    [21] 刘士贺, 韩旭, 刘倩, 等.静息心率对超高危动脉粥样硬化性心血管疾病患者全因死亡风险的影响.中国循环杂志, 4,9(2):140-147.LIU S H, HAN X, LIU Q, et al.Impact of resting heart rate on all-cause mortality in ultra-high risk atherosclerotic cardiovascular disease patients.Chin Circul J, 4,9(2):140-147.
    [22] 张丽沙, 吴寿岭, 邵郅强, 等.非高密度脂蛋白胆固醇对绝经后女性心血管疾病的影响.中国循环杂志, 4,9(1):61-67.ZHANG L S, WU S L, SHAO Z Q, et al.Impact of baseline non-high-density lipoprotein cholesterol level on new-onset cardiovascular disease among postmenopausal women.Chin Circul J, 4,9(1):61-67.
    [23] GUO L, TIAN F, WANG J, et al.Effect of 10-year cumulative blood pressure exposure on atherosclerotic cardiovascular disease of different age groups:Kailuan cohort study.Front Cardiovasc Med, 4,1:1341097.
    [24] LUO J, THOMASSEN J Q, NORDESTGAARD B G, et al.Neutrophil counts and cardiovascular disease.Eur Heart J, 3,4(47):4953-4964.
    [25] MAO Q, ZHAO J, ZHAO X.Association of non-HDL-C-to-HDL-C ratio with coronary lesions and its prognostic performance in first-onset NSTEMI.Biomark Med, 3,7(1):29-39.
    [26] DI ANGELANTONIO E, SARWAR N, PERRY P, et al.Major lipids, apolipoproteins, and risk of vascular disease.JAMA, 9,2(18):1993-2000.
    [27] WANG S, ZHA L, CHEN J, et al.The relationship between lipoprotein(a) and risk of cardiovascular disease:a Mendelian randomization analysis.Eur J Med Res, 2,7(1):211.
    [28] YANG M, NASR B, LIU J, et al.The association between lipoprotein(a)and atrial fibrillation:a systemic review and Meta-analysis.Clin Cardiol, 3,6(8):899-905.
    [29] LIU L, LIU X, DING X, et al.Lipid levels and new-onset atrial fibrillation in patients with acute myocardial infarction.J Atheroscler Thromb, 3,0(5):515-530.
    [30] ALONSO A, YIN X, ROETKER N S, et al.Blood lipids and the incidence of atrial fibrillation:the multi-ethnic study of atherosclerosis and the framingham heart study.J Am Heart Assoc, 4,3(5):e001211.
    [31] HAYIROGˇLU M , 瘙塁AYLIK F, INAR T, et al.Meta-analysis of the current research on the relationship between blood lipid levels and the occurrence of atrial fibrillation.Heart Lung Circ, 3,2(10):1158-1166.
    [32] PAOLILLO S, RENGO G, PELLEGRINO T, et al.Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure.Eur Heart J Cardiovasc Imaging, 5,6(10):1148-1153.
    [33] LüSCHER T F, CREAGER M A, BECKMAN J A, et al.Diabetes and vascular disease:pathophysiology, clinical consequences, and medical therapy:Part Ⅱ.Circulation, 3,8(13):1655-1661.
    [34] KEDHI E, KENNEDY M W, MAEHARA A, et al.Impact of TCFA on unanticipated ischemic events in medically treated diabetes mellitus:insights from the PROSPECT study.JACC:Cardiovasc Imaging, 7,0(4):451-458.
    [35] ZHOU B, REN H, ZHOU X, et al.Associations of iron status with apolipoproteins and lipid ratios:a cross-sectional study from the China health and nutrition survey.Lipids Health Dis, 0,9(1):140.
    [36] YANG W S, LI R, SHEN Y Q, et al.Importance of lipid ratios for predicting intracranial atherosclerotic stenosis.Lipids Health Dis, 0,9(1):160.
    [37] LI Y, CHEN X, LI S, et al.Non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio serve as a predictor for coronary collateral circulation in chronic total occlusive patients.BMC Cardiovasc Disord, 1,1(1):311.
    [38] SEILER C, STOLLER M, PITT B, et al.The human coronary collateral circulation:development and clinical importance.Eur Heart J, 3,4(34):2674-2682.
    [39] BILLINGER M, KLOOS P, EBERLI F R, et al.Physiologically assessed coronary collateral flow and adverse cardiac ischemic events:a follow-up study in 403 patients with coronary artery disease.J Am Coll Cardiol, 2,0(9):1545-1550.
    [40] SUN X X, LI S, FANG W, et al.Preserved myocardial viability in patients with chronic total occlusion of a single coronary artery.J Nucl Cardiol, 1,8(6):2812-2822.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LIU Luqing, WANG Meixiao, LIU Shihe, ZHANG Xiaoxue, CHEN Yixiu, LIU Zhihui, WU Shouling, WU Yuntao. The effect of cumulative non-high density lipoprotein cholesterol/high density lipoprotein cholesterol exposure on atherosclerotic cardiovascular disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2025,33(1):58-67.

Copy
Share
Article Metrics
  • Abstract:35
  • PDF: 96
  • HTML: 0
  • Cited by: 0
History
  • Received:April 17,2024
  • Revised:June 05,2024
  • Online: January 26,2025
Article QR Code

You are the 52108 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025